[Meningococcal infections. Chemical prevention or preventive vaccination].
D000349:Africa; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000906:Antibodies; D004196:Disease Outbreaks / Q000517:prevention & control; D005060:Europe; D008589:Meningococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D008887:Military Medicine; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014481:United States; D014611:Vaccination; D014765:Viral Vaccines
D000900:Anti-Bacterial Agents; D000906:Antibodies; D010406:Penicillins; D013449:Sulfonamides; D014765:Viral Vaccines; D013411:Sulfadiazine; D012293:Rifampin
Infections méningococciques. Prophylaxie chimique ou vaccination préventive.